Form 4: Arcutis Biotherapeutics Director Patrick J. Heron Reports Acquisition of Shares and Stock Options

Director Patrick J. Heron reports acquisition of common stock and stock options in Arcutis Biotherapeutics.

Summary

• On June 14, 2024, Patrick J. Heron, a director of Arcutis Biotherapeutics, reported acquiring 10,139 shares of common stock and 27,052 stock options.
• The common stock was acquired through Restricted Stock Units (RSUs) granted in connection with his service as a non-employee director.
• The RSUs vest in full on the one-year anniversary of the grant date, contingent upon continuous service.
• The stock options have an exercise price of $8.63 and vest 100% on the first anniversary of June 14, 2024, also subject to continuous service.
• Following these transactions, Heron beneficially owns 18,826 shares of common stock and 27,052 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of shares and options by a director is generally a positive sign, indicating confidence in the company. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of shares and stock options by a director signals confidence in the company's future.
• The vesting schedules tied to continuous service align the director's interests with the long-term success of the company.

Future Outlook

The vesting of the RSUs and stock options is contingent upon the director's continuous service, indicating an expectation of ongoing involvement and commitment.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates the director's recent acquisition of shares and options, which is a common occurrence for directors of publicly traded companies.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.
• The vesting schedules tied to continuous service align the director's interests with the long-term success of the company, benefiting shareholders.

Key Dates